MFDS
- Status: likely_approved
🇰🇷 Refludan in South Korea
Refludan (LEPIRUDIN) regulatory status in South Korea.
Marketing authorisation
Refludan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Refludan approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Refludan in South Korea?
Marketing authorisation holder not available in our data.